FindTrial
Sign In

KidneyIntelX

DIAGNOSTIC_TEST4 trials

Sponsors

Renalytix AI, Inc.

Conditions

Chronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2Chronic Kidney Disease Stage 3Chronic Kidney Disease, Stage 3 (Moderate)Chronic Kidney DiseasesDiabetic Kidney Disease

Unknown Phase

Decision Impact Trial of KidneyIntelX
Active, not recruitingNCT04791358
Renalytix AI, Inc.Diabetic Kidney Disease
Start: 2021-11-01End: 2026-12-01Target: 1500Updated: 2026-08-13
Real World Evidence Clinical Utility Study of KidneyIntelX
RecruitingNCT04802395
Renalytix AI, Inc.Chronic Kidney Diseases, Diabetic Kidney Disease
Start: 2021-03-02End: 2026-12-01Target: 10000Updated: 2026-08-13
Prospective Decision Impact Trial of KidneyIntelX
Active, not recruitingNCT04960514
Renalytix AI, Inc.Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2, Chronic Kidney Disease, Stage 3 (Moderate) +1
Start: 2021-11-22End: 2026-12-01Target: 2000Updated: 2026-08-13
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
Active, not recruitingNCT05198284
Renalytix AI, Inc.Chronic Kidney Diseases, Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2 +2
Start: 2021-11-01End: 2026-11-01Target: 2000Updated: 2026-08-13

Related Papers

A Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Kidney Disease
Journal of Primary Care & Community Health2024-01-018 citations
14-LB: Clinical Utility of KidneyIntelX on Patients with Early-Stage Diabetic Kidney Disease—A Real-World Evidence Study
Diabetes2022-05-31